Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

October 20, 2020
Review
Open Access

Metabolism and immunity in breast cancer

Frontiers of Medicine
Deyu ZhangQinong Ye
October 21, 2020
Review

Targeting Atg4B for cancer therapy: Chemical mediators

European Journal of Medicinal Chemistry
Gaoxia YangJie Liu
October 19, 2020
Review
Open Access

Hypoxia-inducible factors not only regulate but also are myeloid-cell treatment targets

Journal of Leukocyte Biology
Lovis KlingRalph Kettritz
October 20, 2020
Review
Open Access

Carnitine Traffic in Cells. Link With Cancer

Frontiers in Cell and Developmental Biology
Lara ConsoleCesare Indiveri
October 20, 2020

Effectiveness of Ketogenic Diets on the Survival of Adult Oncological Patients

Nutrition and Cancer
Simona Minzer
October 21, 2020
Open Access

Targeting Endothelial Cell Metabolism by Inhibition of Pyruvate Dehydrogenase Kinase and Glutaminase-1

Journal of Clinical Medicine
Céline A SchoonjansBernard Gallez
October 15, 2020
Preprint
Open Access

Nucleolin is expressed in human fetal brain development and reactivated in human glial brain tumors regulating angiogenesis and vascular metabolism

BioRxiv : the Preprint Server for Biology
M. SchwabThomas Walchli
October 20, 2020

APC loss induces Warburg effect via increased PKM2 transcription in colorectal cancer

British Journal of Cancer
Pu-Hyeon ChaKang-Yell Choi
October 13, 2020
Review
Open Access

Systemic Reprogramming of Monocytes in Cancer

Frontiers in Oncology
Máté KissDamya Laoui
October 22, 2020
Open Access

Upregulation of lipid metabolism genes in the breast prior to cancer diagnosis

NPJ Breast Cancer
Natascia MarinoAnna Maria V Storniolo
October 18, 2020
Review
Open Access

LKB1 and cancer: The dual role of metabolic regulation

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Ting-Ting Li, Hai-Bin Zhu
October 14, 2020
Preprint
Open Access

HDAC3 regulates senescence and lineage-specific transcriptional programs in non-small cell lung cancer

BioRxiv : the Preprint Server for Biology
L. J. EichnerReuben J Shaw
October 20, 2020

LncRNA-SNHG7 interferes with miR-34a to de-sensitize gastric cancer cells to cisplatin

Cancer Biomarkers : Section a of Disease Markers
Li-Juan PeiFei-De Liu
October 22, 2020
Review
Open Access

Cancer Metabolism: Phenotype, Signaling and Therapeutic Targets

Cells
Jae Hyung ParkHyunwoo Henry Park
October 18, 2020
Open Access

Genetic Ablation of MiR-22 Fosters Diet-Induced Obesity and NAFLD Development

Journal of Personalized Medicine
Monika GjorgjievaMichelangelo Foti

Sign up to follow this feed and discover related papers.

Related Feeds

Aging Genetics (Keystone)

This feed focuses on aging epidemiology and genetic, epigenetic, and proteomic aspects underlying aging, as well as aging- associated biomarkers. Here the latest research in this domain.

Anthracycline Sensitivity & Chromatin (Keystone)

Anthracyclines are used in the treatment of cancer and work by inhibiting topoisomerase II (TOP2). Recent evidence suggests that because DNA accessibility is crucial for TOP2 binding, chromatin regulatory genes should predict anthracycline response. Find the latest research on anthracycline sensitivity and chromatin regulators in this feed.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.

Cancer Epigenetics and Chemical Tools (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Using novel chemical tools allows us to learn more about these epigenetic changes and how they impact the neoplastic process. Follow this feed to learn more about cancer epigenetics and chemical tools.

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.

© 2020 Meta ULC. All rights reserved
/feed-previews/cancer-metabolic-reprogramming/1f9d5e0f-b3db-479d-82d2-aa0b28f3b482